CVR number 41015535
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Selskabet CW ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  29.0% 8.8% 7.7% 9.5% 13.8%  
Credit score (0-100)  3 28 30 25 15  
Credit rating  B BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Net sales  0 0 0 0 0  
Gross profit  0.0 193 360 60.3 -0.2  
EBITDA  0.0 -86.3 109 1.1 -0.2  
EBIT  0.0 -86.3 109 1.1 -0.2  
Pre-tax profit (PTP)  0.0 -86.8 108.8 0.2 -0.2  
Net earnings  0.0 -68.4 83.4 0.2 -0.1  
Pre-tax profit without non-rec. items  0.0 -86.8 109 0.2 -0.2  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 -28.4 55.0 55.2 55.0  
Interest-bearing liabilities  0.0 460 107 132 172  
Balance sheet total (assets)  0.0 665 277 534 240  
Net Debt  0.0 166 -79.9 -90.7 -40.1  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 193 360 60.3 -0.2  
Gross profit growth  0.0% 0.0% 86.2% -83.3% 0.0%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 665 277 534 240  
Balance sheet change%  0.0% 0.0% -58.4% 92.8% -55.1%  
Added value  0.0 -86.3 109.0 1.1 -0.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 1.0 2.0 -1.0  

Profitability 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -44.7% 30.3% 1.9% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -12.5% 22.6% 0.3% -0.0%  
ROI %  0.0% -18.8% 35.3% 0.7% -0.1%  
ROE %  0.0% -10.3% 23.2% 0.3% -0.2%  

Solidity 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Equity ratio %  0.0% -4.1% 19.9% 10.3% 22.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -192.7% -73.3% -7,972.7% 22,900.6%  
Gearing %  0.0% -1,622.2% 194.1% 239.7% 312.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.2% 0.3% 0.8% 0.0%  

Liquidity 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Quick Ratio  0.0 1.0 1.2 1.1 1.3  
Current Ratio  0.0 1.0 1.2 1.1 1.3  
Cash and cash equivalent  0.0 293.7 186.7 223.0 211.8  

Capital use efficiency 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -28.4 55.0 55.2 55.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -0  
EBIT / employee  0 0 0 0 -0  
Net earnings / employee  0 0 0 0 -0